(Q33178132)

23 July 2017

title

Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA. (English)

1 reference

23 July 2017

B Mestre

1

1 reference

23 July 2017

A Arzumanov

2

1 reference

23 July 2017

M Singh

3

1 reference

23 July 2017

F Boulmé

4

1 reference

23 July 2017

S Litvak

5

1 reference

23 July 2017

M J Gait

6

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

Biochimica et Biophysica Acta

23 July 2017

published in

1 reference

23 July 2017

volume

1445

1 reference

23 July 2017

issue

1

1 reference

23 July 2017

page(s)

86-98

1 reference

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Mapping of HIV-1 Tat protein sequences required for binding to Tar RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Keto/Enol Epoxy Steroids as HIV-1 Tat Inhibitors: Structure-Activity Relationships and Pharmacophore Localization

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Specific recognition of HIV-1 TAR RNA by a D-Tat peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Discovery of selective, small-molecule inhibitors of RNA complexes--I. The Tat protein/TAR RNA complexes required for HIV-1 transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Binding of Hoechst 33258 to the TAR RNA of HIV-1. Recognition of a pyrimidine bulge-dependent structure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Antisense inhibitors of HIV: Problems and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Specific inhibition of in vitro reverse transcription using antisense oligonucleotides targeted to the TAR regions of HIV-1 and HIV-2

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Chemical cross-linking of the human immunodeficiency virus type 1 Tat protein to synthetic models of the RNA recognition sequence TAR containing site-specific trisubstituted pyrophosphate analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Site-specific cross-linking of amino acids in the basic region of human immunodeficiency virus type 1 Tat peptide to chemically modified TAR RNA duplexes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potency

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Synthesis and hybridization studies on two complementary nona(2'-O-methyl)ribonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Antisense oligonucleotides made of 2'-O-alkylRNA: their properties and applications in RNA biochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Advantages of 2'-O-methyl oligoribonucleotide probes for detecting RNA targets

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Exploiting the potential of antisense: beyond phosphorothioate oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

RNase H is responsible for the non-specific inhibition of in vitro translation by 2'-O-alkyl chimeric oligonucleotides: high affinity or selectivity, a dilemma to design antisense oligomers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Delivery of oligonucleotides and polynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

Dual-Specificity Interaction of HIV-1 TAR RNA with Tat Peptide-Oligonucleotide Conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900019-6

7 January 2021

10.1016/S0167-4781(99)00019-6

Identifiers

DOI

1 reference

23 July 2017

1 reference